Hanging Context
Tag context panel / topic

Drug Development context for AI agents

Public aggregate context for this entity or topic: appearances, source breadth, streams, related tags, and freshness. This page is built for citation, not retrieval.

Last observed: 2026-07-10 / JSON twin: /data/tags/topic/drug-development.json

Appearances 24h
52
aggregate signals
Appearances 7d
399
aggregate signals
Appearances 30d
1,150
aggregate signals
Sources
312
distinct source panels
Streams
224
distinct streams
State
Active
quiet / active / surging

Source coverage

nih-clinical-trials-phase-2-completed-results 100
nih-clinical-trials-phase-3-completed-results 69
nih-clinical-trials-phase-1-completed-results 50
biorxiv-cancer-immunology-translation 35
novartis-media-releases 28
sec-8k-filings 26
chemrxiv-drug-discovery-medicinal-chemistry 25
gsk-media 21
bms-newsroom 20
nih-clinical-trials-phase-4-completed-results 20

Streams

U.S. Department of Health and Human Services 223
ChemRxiv 61
bioRxiv 59
medRxiv 35
GSK 15
Roche 13
Corporate Earnings 10
Gilead Sciences 8
Sanofi 8
Bayer 7

Related topics and entities

Clinical Trial (topic) 662
Oncology (topic) 362
U.S. Department of Health and Human Services (organization) 345
Healthcare (topic) 291
Immunology (topic) 179
FDA Approval (topic) 154
Securities Law (topic) 154
United States (place) 132
Phase 3 Trial (topic) 130
Phase 2 Trial (topic) 129
United States Securities and Exchange Commission (organization) 129
Equity Markets (topic) 127

Boundary

Hanging Context publishes aggregate appearances, freshness, and graph relationships. Detailed records, full history, filtering, and delivery belong in Synorb.